Project Grant R01HL174599
Award Date
9/15/24
Completion Date
6/30/29
Dollars Obligated
$715K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Tucson, AZ 85724, USA
Similar Awards
The Project Grant award K23HL163253, totaling $178,783, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will support Dr. Pappalardo's research to understand barriers and develop targeted implementation strategies for school-based stock inhaler programs, with the goal of improving asthma management and reducing health disparities. The grant will fund a community-engaged, implementation science...
The federal Project Grant award K23HL174407 for $164,453.00, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to investigate multifactorial asthma determinants in underresourced pediatric populations. The Arkansas Children's Research Institute (ACRI), a non-profit pediatric medical research center, is the prime awardee for this 4-year project that will run from Sep 2024 to Jul 2028. The research...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $797,130 to The Children's Hospital of Philadelphia (CHOP) to conduct a cluster-randomized trial evaluating implementation strategies for Single Maintenance and Reliever Therapy (SMART) in the management of moderate-to-severe pediatric asthma. The study aims to: (1) compare the effects of electronic health record-based clinical...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $154,861 to Children's Research Institute to advance research on social adversity and asthma morbidity among children. The key objectives of the 5-year award are to: 1) develop a population-based machine learning model to predict asthma-related hospitalization risk among children in Washington, D.C. using social adversity, clinical,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,284,920 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Arkansas Children's Research Institute. The grant supports a 5-year study titled "ENSURING ACCESS TO OPTIMAL THERAPY IN CF: ENACT STUDY" to analyze population pharmacokinetics of the triple combination therapy for cystic fibrosis, determine associated genetic variants, and assess the relationship between drug concentrations and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to investigate the relationship between social determinants of health (SDOH) and asthma outcomes in Black and Latinx adults. The University of South Florida will receive $274,392 to conduct a large pragmatic randomized controlled trial, the PREPARE study, which previously demonstrated that a 'patient-activated, reliever-triggered inhaled...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $616,814 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Harvard T.H. Chan School of Public Health to conduct research on the role of microRNAs in regulating airway smooth muscle function and their impact on asthma. The overarching goal is to establish the in vivo function of key microRNAs in regulating airway smooth muscle properties and airway hyperresponsiveness, as well as to determine how...
This Project Grant award of $673,581 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to assess disparities in asthma care between Latino and non-Hispanic white adults and identify underlying factors. The awardee, Ochin, Inc., a nonprofit health IT collaborative, will leverage a unique dataset from a national network of community health centers to evaluate how social determinants of health impact asthma care...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $393,180 to Texas Woman's University to develop and validate a new questionnaire assessing asthma self-management behaviors in adolescents aged 12-21. The goal is to create a reliable and valid measure to facilitate assessment and feedback on asthma self-management in clinical settings and provide a research tool to better understand this critical issue. The...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837) provides $387,116 to the University of South Florida (USF) to investigate the sensory neuronal mechanisms underlying the development of house dust mite-induced airway hyperreactivity, a key characteristic of asthma. The 5-year project, running from May 1, 2025 to April 30, 2030, aims to define the specific nerve subtypes and signaling...